Debating deposits:An interobserver variability study of lymph nodes and pericolonic tumor deposits in colonic adenocarcinoma

Archives of Pathology and Laboratory Medicine

Volumn 138, Issue 5, 2014, Pages 636-642

  Rock, Jonathan B ^a   Washington, M Kay ^b   Adsay, N Volkan ^c   Greenson, Joel K ^d   Montgomery, Elizabeth A ^e   Robert, Marie E ^f   Yantiss, Rhonda K ^g   Lehman, Amy M ^h   Frankel, Wendy L ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e DEPARTMENT OF PATHOLOGY   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

^h OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTIN;

ADENOCARCINOMA; ADIPOSE TISSUE; COLON TUMOR; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHOCYTE; OBSERVER VARIATION; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY;

ADENOCARCINOMA; ADIPOSE TISSUE; COLONIC NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; ELASTIN; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOCYTES; OBSERVER VARIATION; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84900477535     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2013-0166-OA     Document Type: Conference Paper

References (37)

1. National Comprehensive Cancer Network. NCCN Guidelines Insights - Localized Colon Cancer, Version 3.2013. http://education.nccn.org/node/19845. Accessed November 5, 2012.
2. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer-Verlag; 2010:143-164.
3. Sobin LH, Gospodarowicz M, Wittekind C. IUCC TNM Classification of Malignant Tumours. 7th ed. Hoboken, NJ: Wiley-Blackwell; 2009:100-105.
4. Fleming ID, Cooper JS, Hensen DE, et al. AJCC Cancer Staging Manual. 5thed. Philadelphia, PA: Lippincott-Raven Publishers; 1997:83-88.
5. Sobin LH, Wittekind C. IUCC TNM Classification of Malignant Tumours.5th ed. Hoboken, NJ: John Wiley & Sons; 1997.
6. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6thed. New York, NY: Springer-Verlag; 2002:113-124.
7. Sobin LH, Wittekind C. IUCC TNM Classification of Malignant Tumours.6th ed. Hoboken, NJ: John Wiley & Sons; 2002:72-76.
8. Fleiss JL, Cuzick J. The reliability of dichotomous judgments: unequalnumbers of judges per subject. Appl Psychol Meas. 1979;3(4):537-542.
9. Zou GY, Donner A. Confidence interval estimation of the intraclasscorrelation coefficient for binary outcome data. Biometrics. 2004;60(3):807-811. (Pubitemid 39181127)
10. Lui KK, Enjoji M, Inokuchi K. Venous permeation of colorectal carcinoma.Jpn J Surg. 1980;10(4):284-289. (Pubitemid 11132347)
11. Suzuki A, Togashi K, Nokubi M, et al. Evaluation of venous invasion by elastica van Gieson stain and tumor budding predicts local and distant metastasesin patients with T1 stage colorectal cancer. Am J Surg Pathol. 2009;33(11):1601-1607.
12. Sato T, Ueno H, Mochizuki H, et al. Objective criteria for the grading ofvenous invasion in colorectal cancer. Am J Surg Pathol. 2010;34(4):454-462.
13. Ueno H, Mochizuki H. Hashiguchi Y, et al. Extramural cancer deposits without nodal structure in colorectal cancer: optimal categorization for prognostic staging. Am J Clin Pathol. 2007;127(2):287-294. (Pubitemid 46797188)
14. Tong L, Gao P, Wang Z. Is the seventh edition of the UICC/AJCC TNM staging system reasonable for patients with tumor deposits in colorectal cancer? Ann Surg. 2012;255(2):208-213.
15. Lo DS, Pollett A, Siu LL, et al. Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer. Cancer. 2008;112(1):50-54.
16. Ueno H, Mochizuki H, Tamakuma S. Prognostic significance of extranodal microscopic foci discontinuous with primary lesion in rectal cancer. Dis Colon Rectum. 1998;41(1):744-749.
17. Prabhudesai A, Arif S, Finlayson CJ, et al. Impact of microscopic extranodal tumor deposits on the outcome of patients with rectal cancer. Dis Colon Rectum. 2003;46(11):1531-1537. (Pubitemid 37429736)
18. Puppa G, Maisonneuve P, Sonzogni A, et al. Pathological assessment of pericolonic tumor deposits in advanced colonic carcinoma: relevance to prognosis and tumor staging. Mod Pathol. 2007;20(8):843-855. (Pubitemid 47077266)
19. Nagtegaal ID, Quirke P. Colorectal tumour deposits in the mesorectum and pericolon; a critical review. Histopathology. 2007;51(2):141-149. (Pubitemid 47083979)
20. Alexander J, Watanabe T, Wu TT, et al. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol. 2001;158(2):527-535. (Pubitemid 32158613)
21. Harrison JC, Dean PJ, el-Zeky F, et al. Impact of the Crohn's-like lymphoid reaction on staging of right-sided colon cancer: results of multivariate analysis. Hum Pathol. 1995;26(1):31-38.
22. Buckowitz A, Knaebel HP, Benner A, et al. Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. Br J Cancer. 2005;92(9):1746-1753. (Pubitemid 40756487)
23. Jenkins MA, Hayashi S, O'Shea AM, et al. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology. 2007;133(1):48-56. (Pubitemid 47039240)
24. Nagtegaal ID, Tot T, Jayne DG, et al. Lymph nodes, tumor deposits andTNM: are we getting better? J Clin Oncol. 2011;29(18):2487-2492.
25. Quirke P, Williams GT, Ectors N, et al. The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol. 2007;8(7):651-657. (Pubitemid 46995637)
26. Quirke P, Cuvelier C, Ensari A. Evidence-based medicine: the time has come to set standards for staging. J Pathol. 2010;221(4):357-360.
27. Goldstein NS, Turner Jr. Pericolonic tumor deposits in patients with T3N+M0 colon adenocarcinomas: markers of reduced disease free survival and intra-abdominal metastasis and their implications for TNM classification. Cancer.2000;88(10):2228-2238. (Pubitemid 30247121)
28. Ueno H, Mochizuki H, Shirouzu K. Multicenter study for optimal categorization of extramural tumor deposits for colorectal cancer staging. Ann Surg. 2012;255(4):739-746.
29. Goldstein NS, Sanford W, Coffey M, et al. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma: trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol. 1997;106(2):209-216. (Pubitemid 26277211)
30. Goldstein NS. Lymph node recoveries from 2,427 pT3 colorectal resection specimens spanning 45 years: recommendation for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol. 2002;26(2):179-189. (Pubitemid 34127497)
31. Herrera-Ornelas L, Justiniano J, Castillo N, et al. Metastases in small lymphnodes from colon cancer. Arch Surg. 2987;122(11):1253-1256.
32. Joseph NE, Sigurdson ER, Hanlon AL, et al. Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol. 2003;10(3):213-218. (Pubitemid 40486952)
33. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of Intergroup Trial Int-0089. J Clin Oncol. 2003;21(15):2912-2919. (Pubitemid 46621841)
34. Huh JW, Kim YJ, Kim HR. Distribution of lymph nodes metastases is an independent predictor of survival for sigmoid colon and rectal cancer. Ann Surg. 2012;255(1):70-78.
35. Kobayashi H, Ueno H, Hashiguchi Y, Mochizuki H. Distribution of lymph node metastasis is a prognostic index in patients with stage III colon cancer. Surgery. 2006;139(4):516-522.
36. Lykke J, Roikjaer O, Jess P, et al. The relation between lymph node status and survival in stage I-III colon cancer: results from a prospective nationwide cohort study. Colorectal Dis. 2013;15(5):559-565.
37. Sjo OH, Merok MA, Svindland A, et al. Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer. Dis Colon Rectum. 2012;55(3):307-315.